Insider Transactions Reported by 8 Insiders of Protagenic Therapeutics, Inc.\new

Symbol
PTIX, PTIXW on OTC
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Protagenic Therapeutics, Inc.\new executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Garo H. Armen Executive Chairman, Director, 10%+ Owner $435,000 25 Mar 2024
Alexander K. Arrow Chief Financial Officer $211,110 25 Mar 2024
Robert Benjamin Stein Director $130,500 25 Mar 2024
Jennifer Buell Director $130,500 25 Mar 2024
Brian Corvese Director $76,125 25 Mar 2024
Barrett Evans ex CEO, Director, 10%+ Owner $67,204 15 May 2025
Khalil Barrage Director $39,150 25 Mar 2024
Timothy R. Wright Director $36,975 25 Mar 2024

Recent Insider Transactions by Companies or Individuals for Protagenic Therapeutics, Inc.\new

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Barrett Evans PTIX Preferred Stock Series D 0 1,000 15 May 2025 These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member.
Barrett Evans PTIX Preferred Stock Series D 0 4,498 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Barrett Evans PTIX Preferred Stock Series D 0 1,000 15 May 2025 Direct
Barrett Evans PTIX Preferred Stock Series C-1 0 131,034 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Barrett Evans PTIX Preferred Stock Series C 0 787 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Barrett Evans PTIX Common Stock 0 16,233 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.